Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Propofol or remimazolam dose comparison for sufentanil ED50 during tracheal intubation in elderly patients
ChiCTR2300072785Phase 4Not yet recruiting
- Sponsor
- Jiaxing Second Hospital
- Start
- Jul 2023
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of propofol, remimazolam and sufentanil (4 arms), sponsored by Jiaxing Second Hospital. Primary endpoint: Tracheal intubation reaction. Planned start Jul 2023; status: not yet recruiting.
02
Drugs
propofolremimazolamsufentanil
Beyond the preview
Go deeper on ChiCTR2300072785.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2300072785.